PL443102A1 - A new azetidine-2,4-dione derivative, a method for obtaining a new azetidine-2,4-dione derivative and the use of a new azetidine-2,4-dione derivative - Google Patents

A new azetidine-2,4-dione derivative, a method for obtaining a new azetidine-2,4-dione derivative and the use of a new azetidine-2,4-dione derivative

Info

Publication number
PL443102A1
PL443102A1 PL443102A PL44310222A PL443102A1 PL 443102 A1 PL443102 A1 PL 443102A1 PL 443102 A PL443102 A PL 443102A PL 44310222 A PL44310222 A PL 44310222A PL 443102 A1 PL443102 A1 PL 443102A1
Authority
PL
Poland
Prior art keywords
dione derivative
new azetidine
azetidine
new
obtaining
Prior art date
Application number
PL443102A
Other languages
Polish (pl)
Other versions
PL249026B1 (en
Inventor
Krzysztof Zbigniew Łączkowski
Beata Donarska
Original Assignee
Uniwersytet Mikołaja Kopernika W Toruniu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Mikołaja Kopernika W Toruniu filed Critical Uniwersytet Mikołaja Kopernika W Toruniu
Priority to PL443102A priority Critical patent/PL249026B1/en
Publication of PL443102A1 publication Critical patent/PL443102A1/en
Publication of PL249026B1 publication Critical patent/PL249026B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest nowa pochodna azetydyno-2,4-dionu, sposób otrzymywania nowej pochodnej azetydyno-2,4-dionu i zastosowanie nowej pochodnej azetydyno-2,4-dionu.The subject of the invention is a new azetidine-2,4-dione derivative, a method for obtaining a new azetidine-2,4-dione derivative and the use of a new azetidine-2,4-dione derivative.

PL443102A 2022-12-09 2022-12-09 Novel azetidine-2,4-dione derivative, method for preparation of novel azetidine-2,4-dione derivative and application of novel azetidine-2,4-dione derivative PL249026B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL443102A PL249026B1 (en) 2022-12-09 2022-12-09 Novel azetidine-2,4-dione derivative, method for preparation of novel azetidine-2,4-dione derivative and application of novel azetidine-2,4-dione derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL443102A PL249026B1 (en) 2022-12-09 2022-12-09 Novel azetidine-2,4-dione derivative, method for preparation of novel azetidine-2,4-dione derivative and application of novel azetidine-2,4-dione derivative

Publications (2)

Publication Number Publication Date
PL443102A1 true PL443102A1 (en) 2023-05-15
PL249026B1 PL249026B1 (en) 2026-02-23

Family

ID=86325368

Family Applications (1)

Application Number Title Priority Date Filing Date
PL443102A PL249026B1 (en) 2022-12-09 2022-12-09 Novel azetidine-2,4-dione derivative, method for preparation of novel azetidine-2,4-dione derivative and application of novel azetidine-2,4-dione derivative

Country Status (1)

Country Link
PL (1) PL249026B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022507267A (en) * 2018-11-13 2022-01-18 バイオセリックス， インコーポレイテッド Substituted isoindolinone
EP3891128A4 (en) * 2018-12-05 2022-08-17 Vividion Therapeutics, Inc. Substituted isoindolinones as modulators of cereblon-mediated neo-substrate recruitment
WO2020243379A1 (en) * 2019-05-31 2020-12-03 Celgene Corporation Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith

Also Published As

Publication number Publication date
PL249026B1 (en) 2026-02-23

Similar Documents

Publication Publication Date Title
MX2022007527A (en) Kras mutant protein inhibitors.
MX2021014443A (en) Tead inhibitors and uses thereof.
PH12021553018A1 (en) New egfr inhibitors
PH12022553269A1 (en) Composition, kit and method for detecting sars-cov-2 and use thereof
MX2023014154A (en) ANTI-CCR8 ANTIBODIES.
CL2021002167A1 (en) Synthesis of omecamtiv mecarbil (divisional of application no. 201903898)
MX2020007947A (en) ERBB/BTK INHIBITORS.
JOP20230170A1 (en) CDK2 inhibitors and methods for using them
BR112022003357A2 (en) Heterocyclic compounds
CO2025012210A2 (en) Polymorph as a protein kinase inhibitor mek, method of preparation and use thereof
GEAP202416390A (en) Bicyclic heteroaromatic inhibitors of klk5
PL443102A1 (en) A new azetidine-2,4-dione derivative, a method for obtaining a new azetidine-2,4-dione derivative and the use of a new azetidine-2,4-dione derivative
CL2021000531A1 (en) Methods of using a phenoxypropylamine compound to treat pain.
ZA202106519B (en) Caspase inhibitors and methods of use thereof
JOP20230205A1 (en) Vmat2 inhibitors and methods of use
CL2024003050A1 (en) Method and intermediate for the preparation of apalutamide.
EA202192237A1 (en) CRYSTALLINE FORMS OF THE JAK2 INHIBITOR
PL437991A1 (en) Method of isolation and cultivation of strains, strains, their application, medium for their cultivation and form of scytonemin
WO2022261534A3 (en) Three-dimensional cell-laden bioink scaffolds and methods of making the same under cryogenic conditions for tissue engineering
PL448768A1 (en) C20-aminosalinomycin derivative compound and method of obtaining it
MX2021008102A (en) COMPOSITION FOR THE DIAGNOSIS OR TREATMENT OF CONDITIONS ASSOCIATED WITH INCREASED ACTIVITY OF EUKARYOTIC TRANSLATION INITIATION FACTOR 4E (EIF4E) COMPRISING AN EIF4E INHIBITOR.
PL446115A1 (en) Core-bending pyridinium derivatives based on borate clusters, method of their preparation and use
UY5223S (en) Ornament
CA221413S (en) RING
PL445003A1 (en) Pharmaceutical composition, especially for cancer treatment, and its application